Conformed Copy
SECURITIES PURCHASE AGREEMENT
(CONVERTIBLE DEBENTURES)
THIS SECURITIES PURCHASE
AGREEMENT (the
“Agreement”), dated as of March 28, 2005, is entered
into by and among Eye Care International, Inc. , a Delaware
corporation (the “Company”), having its address at 1511
North Westshore Boulevard, Suite 925, Tampa, Florida 33607, and
each entity named on the signature page hereto as a buyer and the
permitted assigns of such entity (each, a “Buyer”)
(each agreement with a Buyer being deemed a separate and
independent agreement between the Company and such Buyer, except
that each Buyer acknowledges and consents to the rights granted to
each other Buyer under this Agreement and the Transaction Documents
(as defined below)).
W I T N E S S E T
H:
WHEREAS , the Company and the Buyers are executing and
delivering this Agreement in accordance with and in reliance upon
the exemption from securities registration afforded, inter
alia , by Rule 506 under Regulation D (“Regulation
D”) as promulgated by the United States Securities and
Exchange Commission (the “SEC”) under the Securities
Act of 1933, as amended (the “1933 Act”), and/or
Section 4(2) of the 1933 Act; and
WHEREAS, the Buyers severally, and not jointly, wish to
purchase, upon the terms and subject to the conditions of this
Agreement, a minimum aggregate amount of $250,000 and a maximum
aggregate amount of $1,000,000 of convertible debentures of the
Company (the “Debentures”), which will be convertible
into shares of the Company’s Class A Common Stock, par value
$0.001 per share (the “Common Stock”), upon the terms
and subject to the conditions of the Debentures, and subject to
acceptance of this Agreement by the Company;
NOW THEREFORE
, in consideration of the premises
and the mutual covenants contained herein and other good and
valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties agree as follows:
|
1.
|
AGREEMENT TO PURCHASE; PURCHASE
PRICE.
|
|
|
|
|
|
|
a.
Purchase
(i) The
undersigned Buyers hereby severally agree to purchase the
Debentures from the Company on the terms and conditions set forth
below in this Agreement and the other Transaction Documents (as
defined below).
(ii) Subject
to the terms and conditions of this Agreement and the other
Transaction Documents the Buyers will purchase the Debentures at
one or more closings (each, a “Closing”) to be held on
the respective Closing Dates (as defined below).
(iii) The
purchase price to be paid respectively by the Buyers shall equal
100% of the face amount of the Debentures being purchased on the
Closing Date by each Buyer as set forth on the signature page to
this Agreement.
b.
Certain Definitions. As used herein, each of the following
terms has the meaning set forth below, unless the context otherwise
requires:
(i) “Affiliate”
means, with respect to a specific Person referred to in the
relevant provision, another Person who or which controls or is
controlled by or is under common control with such specified
Person.
(ii) “Certificates”
means the relevant Debentures duly executed on behalf of the
Company and issued in the name of the respective Buyer.
(iii) “Closing
Date” means the respective dates on which the Closings
referred to in this Agreement are held.
(iv) “Conversion
Shares” means the shares of Common Stock issuable upon
conversion of the Debentures.
(v) “Effective
Date” means the effective date of the Registration Statement
covering the Registrable Securities (as those terms are defined in
the Registration Rights Agreement defined below) for the Debentures
issued on the Closing Date.
(vi) “Escrow”
means the Divine Capital Markets LLC EYCI Special Escrow Account
maintained at JP Morgan / Chase Manhattan Bank.
(vii) “Final
Closing Date” shall have the meaning ascribed to such term in
Section 6(d).
(viii) “Person”
means any living person or any entity, such as, but not necessarily
limited to, a corporation, partnership or trust.
|
(ix)
|
“Placement Agent” means Divine
Capital Markets, LLC.
|
|
|
(x)
|
“Purchase Price” means the purchase
price for the Debentures.
|
|
(xi)
|
“Securities” means the Debentures
and Conversion Shares.
|
|
|
|
|
|
|
(xii) “Shares”
means the Conversion Shares and the shares issued to the Placement
Agent or any of its designees in connection with its services in
connection with this offering of Debentures.
c.
Form of Payment; Delivery of Certificates. Each of the
Buyers shall pay the Purchase Price for the Debentures to be
purchased by such Buyer by delivering immediately available good
funds in United States Dollars to the Escrow prior to the
respective Closing on the applicable Closing Date, determined as
provided in Section 6.
(ii) Promptly
following payment to the Company from the Escrow of the Purchase
Price to be paid for the purchase of the Debentures being purchased
by such Buyer, the Company shall deliver to the Buyers the
Certificates purchased at such Closing.
2
d.
Payment to the Escrow. All payments to the Escrow for the
purchase of the Debentures shall be made at or prior to the Closing
by wire transfer of funds to the Escrow, as follows:
|
Beneficiary
Account Name:
|
Divine Capital
Markets LLC
|
|
|
EYCI Special
Escrow Account
|
|
|
|
|
Beneficiary Account No.:
|
217-633 623 1-65
|
|
|
|
|
FBO: EYCI,
Special Account for Exclusive Benefit of Clients of DCM
|
|
|
|
|
ABA/Transit
No.:
|
021-000-021
|
|
|
|
|
Beneficiary
Bank:
|
JP Morgan /
Chase Manhattan Bank
|
|
|
1 Chase
Manhattan Plaza
|
|
|
New York, New
York 10004
|
2. BUYERS
REPRESENTATIONS, WARRANTIES, ETC.; ACCESS TO INFORMATION;
INDEPENDENT INVESTIGATION.
Each Buyer represents and warrants
to, and covenants and agrees with, the Company as
follows:
a. Without
limiting any Buyer’s right to sell the Common Stock pursuant
to the Registration Statement, each Buyer is purchasing the
Debentures and will be acquiring the Conversion Shares for its own
account for investment only and not with a view towards the public
sale or distribution thereof and not with a view to or for sale in
connection with any distribution thereof.
b. Each Buyer
is (i) an “accredited investor” as that term is defined
in Rule 501 of the General Rules and Regulations under the 1933 Act
by reason of Rule 501(a)(3), (ii) experienced in making investments
of the kind described in this Agreement and the related documents,
(iii) able, by reason of the business and financial experience of
its officers (if an entity) and professional advisors (who are not
affiliated with or compensated in any way by the Company or any of
its affiliates or selling agents), to protect its own interests in
connection with the transactions described in this Agreement, and
the related documents, and (iv) able to afford the entire loss of
its investment in the Securities.
c. All
subsequent offers and sales of the Securities by each Buyer shall
be made pursuant to registration of the Shares under the 1933 Act
or pursuant to an exemption from registration and compliance with
applicable states’ securities laws.
d. Each Buyer
understands that the Securities are being offered and sold to it in
reliance on specific exemptions from the registration requirements
of United States federal and state securities laws and that the
Company is relying upon the truth and accuracy of, and the
Buyer’s compliance with, the representations, warranties,
agreements, acknowledgments and understandings of the Buyers set
forth herein in order to determine the availability of such
exemptions and the eligibility of the Buyers to acquire the
Securities.
3
e. Each Buyer
and its advisors, if any, have been furnished with all materials
relating to the business, finances and operations of the Company
and materials relating to theoffer and sale of the Securities which
have been requested by the Buyer. Each Buyer and its advisors, if
any, have been afforded the opportunity to ask questions of the
Company and have received complete and satisfactory answers to any
such inquiries. Without limiting the generality of the foregoing,
each Buyer has also had the opportunity to obtain and to review the
Company’s (1) Annual Report on Form 10-KSB for the fiscal
year ended December 31, 2003, filed April 28, 2004, (2) Quarterly
Report on Form 10-QSB for the period ended March 31, 2004 filed May
24, 2004, (3) Quarterly Report on Form 10-QSB for the period ended
June 30, 2004 filed September 8, 2004, (4) Amendment to Quarterly
Report on Form 10-QSB for the period ended June 30, 2004 filed
October 19, 2004, (5) Quarterly Report on Form 10-QSB for the
period ended September 30, 2004 filed November 23, 2004 and (6)
Registration Statement on Form SB-2/A filed February 10, 2005 (the
“Pending SB-2” and together with the other documents
referred to in the preceding clauses (1) through (5), the
“Company’s SEC Documents”).
f. Each
Buyer understands that its investment in the Securities involves a
high degree of risk, including the risk of the loss of the
Buyer’s entire investment.
g. Each Buyer
understands that no United States federal or state agency or any
other government or governmental agency has passed on or made any
recommendation or endorsement of the Securities.
h. Each Buyer
is duly organized, validly existing and in good standing under the
laws of the jurisdiction of its organization. This Agreement and
the other Transaction Documents have been duly and validly
authorized, executed and delivered on behalf of the Buyer and
create a valid and binding agreement of the Buyer enforceable in
accordance with its terms, subject as to enforceability to general
principles of equity and to bankruptcy, insolvency, moratorium and
other similar laws affecting the enforcement of creditors’
rights generally.
i. Such
Buyer has not employed any broker or finder in connection with the
transactions contemplated by this Agreement.
j. The
state in which any offer to purchase shares hereunder was made to
or accepted by such Buyer is the state shown as the Buyer’s
address on Schedule I hereto.
k. Each Buyer
was not formed for the purpose of investing solely in the
Securities which may be acquired hereunder.
l. Each
Buyer is able to bear the complete loss of such Buyer’s
investment in the Securities.
m. Each
Buyer’s execution, delivery and performance under this
Agreement will not breach the provisions of any agreement to which
such Buyer is a party.
4
3.
COMPANY REPRESENTATIONS, ETC. The Company represents and
warrants to the Buyers that:
a.
Concerning the Debentures and the Shares. There are no
preemptive rights of any stockholder of the Company to acquire the
Debentures or the Shares.
b.
Reporting Company Status. The Company is a corporation duly
organized, validly existing and in good standing under the laws of
the State of Delaware and has the requisite corporate power to own
its properties and to carry on its business as now being conducted.
The Company is duly qualified as a foreign corporation to do
business and is in good standing in the State of Florida and in
each other jurisdiction where the nature of the business conducted
or property owned by it makes such qualification necessary, other
than those jurisdictions in which the failure to so qualify would
not have a material adverse effect on the business, operations or
condition (financial or otherwise) or results of operation of the
Company and its subsidiaries taken as a whole (a “Material
Adverse Effect”). The Company has registered its Common Stock
pursuant to Section 12 of the Securities Exchange Act of 1934, as
amended (the “1934 Act”), and the Common Stock is
listed and traded on the OTC Bulletin Board Market of the National
Association of Securities Dealers, Inc. (trading symbol: EYCI). The
Company has received no notice, either oral or written, with
respect to the continued eligibility of the Common Stock for such
listing, and the Company has maintained all requirements for the
continuation of such listing.
c.
Authorized Shares. The authorized capital stock of the
Company consists of 120,000,000 shares of capital stock, of which
80,000,000 shares are designated as Class A Common Stock, par value
$0.001 per share (the “Common Stock”), 20,000,000
shares are designated Class B Common Stock, par value $0.001 per
share and 20,000,000 shares are designated as Preferred Stock. As
of the date hereof, assuming the conversion or exercise of certain
currently outstanding common stock equivalents of the Company into
underlying shares of Common Stock, 23,807,147 shares of Common
Stock (excluding an additional approximately 2,676,344 shares of
Common Stock to be issued upon conversion of certain currently
outstanding debentures and exercise of certain currently
outstanding warrants), 5,302,802 shares of Class B Common Stock and
155 Series A Convertible Preferred Shares and 86 Series C Mandatory
Convertible Preferred Shares of stock are issued and outstanding.
All issued and outstanding shares of Common Stock have been duly
authorized and validly issued and are fully paid and nonassessable.
The Company has sufficient authorized and unissued shares of Common
Stock as may be necessary to effect the issuance of the Shares. The
Shares have been duly authorized and, when issued upon conversion
of, or as interest on, the Debentures will be duly and validly
issued, fully paid and non-assessable and will not subject the
holder thereof to personal liability by reason of being such
holder. At all times, the Issuer shall keep available and reserved
for issuance to the holders of the Debentures Common Stock duly
authorized for issuance against the Debentures.
d.
Securities Purchase Agreement; Registration Rights
Agreement. This Agreement and the Registration Rights
Agreement, between the Company and the Buyers, substantially in the
form of Exhibit C annexed hereto (the “Registration Rights
Agreement”), and the transactions contemplated thereby, have
been duly and validly authorized by the Company, this Agreement has
been duly executed and delivered by the Company. Each of this
Agreement, the Debentures and the Registration Rights Agreement,
when executed and delivered by the Company, are and will be, valid,
legal and binding agreements of the Company enforceable in
accordance with their respective terms, subject as to
enforceability to general principles of equity and to bankruptcy,
insolvency, moratorium, and other similar laws affecting the
enforcement of creditors’ rights generally.
5
e.
Non-contravention. The execution and delivery of this
Agreement, the Debentures and the Registration Rights Agreement by
the Company, the issuance of the Securities, and the consummation
by the Company of the other transactions contemplated by this
Agreement, the Registration Rights Agreement, and the Debentures do
not and will not conflict with or result in a breach by the Company
of any of the terms or provisions of, or constitute a default under
(i) the Certificate of Incorporation or by-laws of the Company,
each as currently in effect, (ii) any indenture, mortgage, deed of
trust, or other material agreement or instrument to which the
Company is a party or by which it or any of its properties or
assets are bound, including any listing agreement for the Common
Stock, except as herein set forth or an event which results in the
creation of any lien, charge or encumbrance upon any assets of the
Company or of any of its subsidiaries or the triggering of any
preemptive or anti-dilution rights or rights of first refusal or
first offer on the part of holders of the Company’s
securities, (iii) to its knowledge, any existing applicable law,
rule, or regulation or any applicable decree, judgment, or order of
any court, United States federal or state regulatory body,
administrative agency, or other governmental body having
jurisdiction over the Company or any of its properties or assets,
or (iv) the Company’s listing agreement for its Common Stock,
except such conflict, breach or default which would not have a
Material Adverse Effect.
f.
Approvals. No authorization, approval or consent of any
court, governmental body, regulatory agency, self-regulatory
organization, or stock exchange or market or the stockholders of
the Company is required to be obtained by the Company for the
issuance and sale of the Securities to the Buyers as contemplated
by this Agreement, except such authorizations, approvals and
consents that have been obtained, or such authorizations, approvals
and consents, the failure of which to obtain would not have a
Material Adverse Affect.
g. SEC
Filings. To the best of the Company's knowledge, none of the
Company’s SEC Documents contained, at the time they were
filed, any untrue statement of a material fact or omitted to state
any material fact required to be stated therein or necessary to
make the statements made therein in light of the circumstances
under which they were made, not misleading. Except as set forth on
Schedule 3(g) to this Agreement, the Company has since
January 1, 2003 timely filed all requisite forms, reports and
exhibits thereto with the SEC. The Company is not aware of any
event occurring on or prior to a Closing Date or the Delivery Date
(other than the transactions effected hereby) that would require
the filing of, or with respect to which the Company intends to
file, a Form 8-K after such date.
h.
Absence of Certain Changes. Since December 31, 2003, there
has been no material adverse change and no material adverse
development in the business, properties, operations, condition
(financial or otherwise), or results of operations of the Company
or any of its subsidiaries, except as disclosed in the
Company’s SEC Documents. Since December 31, 2003, except as
provided in the Company’s SEC Documents, neither the Company
nor any of its subsidiaries has (i) incurred or become subject to
any material liabilities (absolute or contingent) except
liabilities incurred in the ordinary course of business consistent
with past practices; (ii) discharged or satisfied any material lien
or encumbrance or paid any material obligation or liability
(absolute or contingent), other than current liabilities paid in
the ordinary course of business consistent with past practices;
(iii) declared or made any payment or distribution of cash or other
property to stockholders with respect to its capital stock, or
purchased or redeemed, or made any agreements to purchase or
redeem, any shares of its capital stock; (iv) sold, assigned or
transferred any other tangible assets, or canceled any debts or
claims, except in the ordinary
6
course of business consistent with
past practices; (v) suffered any substantial losses or waived any
rights of material value, whether or not in the ordinary course of
business, or suffered the loss of any material amount of existing
business; (vi) made any changes in employee compensation, except in
the ordinary course of business consistent with past practices; or
(vii) experienced any material problems with labor or management in
connection with the terms and conditions of their
employment.
i.
Full Disclosure. There is no fact known to the Company
(other than general economic conditions known to the public
generally or as disclosed in the Company’s SEC Documents)
that has not been disclosed in writing to the Buyers that (i) would
reasonably be expected to have a Material Adverse Effect, (ii)
would reasonably be expected to materially and adversely affect the
ability of the Company to perform its obligations pursuant to this
Agreement or any of the agreements contemplated hereby
(collectively, including this Agreement, the “Transaction
Documents”), or (iii) would reasonably be expected to
materially and adversely affect the value of the rights granted to
the Buyers in the Transaction Documents.
j.
Absence of Litigation. There is no action, suit, proceeding,
inquiry or investigation before or by any court, public board or
body pending or, to the knowledge of the Company, threatened
against or affecting the Company or any of its subsidiaries,
wherein an unfavorable decision, ruling or finding would have a
Material Adverse Effect or which would adversely affect the
validity or enforceability of, or the authority or ability of the
Company and its subsidiaries taken as a whole to perform its
obligations under, any of the Transaction Documents. Neither the
Company nor any of its subsidiaries is a party to or subject to the
provisions of, any order, writ, injunction, judgement or decree of
any court or government agency or instrumentality which could
reasonably be expected to have a Material Adverse
Effect.
k.
Absence of Events of Default. Except as disclosed in the
Company’s SEC Documents, no Event of Default (or its
equivalent term), as defined in the respective agreement,
indenture, mortgage, deed of trust or other instrument to which the
Company or any of its subsidiaries is a party, and no event which,
with the giving of notice or the passage of time or both, would
become an Event of Default (or its equivalent term) (as so defined
in such document), has occurred and is continuing, which would have
a Material Adverse Effect.
l.
Prior Issues. Except as set forth in the Company’s SEC
Documents, during the twelve (12) months preceding the date hereof,
the Company has not issued any convertible securities or any shares
of the Common Stock.
m. No
Undisclosed Liabilities or Events. The Company has no
liabilities or obligations other than those disclosed in the
Company’s SEC Documents or those incurred in the o